Literature DB >> 16890894

Role of B-1a cells in autoimmunity.

Byian Duan1, Laurence Morel.   

Abstract

B-1a cells are distinguished from conventional B cells (B2) by their developmental origin, their surface marker expression and their functions. They were originally identified as a B cell subset of fetal origin that expresses the pan-T cell surface glycoprotein, CD5. B-1a cells also differ from B2 by the expression levels of several surface markers, including IgM, IgD, CD43 and B220 [R. Berland, H.H. Wortis, Origins and functions of B-1 cells with notes on the role of CD5. Ann Rev Immunol, 20 (2002) 253-300.]. The majority of B-1a cells are located in peritoneal and pleural cavities. Compared to B2 cells, B-1a are long-lived, non-circulating, with reduced BCR diversity and affinity [A.B. Kantor, C.E. Merrill, L.A. Herzenberg, J.L. Hillson, An unbiased analysis of V-H-D-J(H) sequences from B-1a, B-1b, and conventional B cells. J Immunol, 158 (1997) 1175-1186.]. B-1a cells are largely responsible for the production of circulating IgM referred to as natural antibodies. These low affinity antibodies are polyreactive and constitute as such a first line of defense against bacterial pathogens [M.C. Carroll, A.P. Prodeus, Linkages of innate and adaptive immunity. Curr Opin Immunol, 10 (1998) 36-40.]. This polyreactivity also results into the recognition of autoantigens, which serves in the clearance of apoptosis products. The weak autoreactivity of the B-1a cells has been postulated to play a role in autoimmune pathogenesis. In addition, other characteristics, such as the production of high level of IL-10 [A. O'Garra, R. Chang, N. Go, R. Hastings, G. Haughton, M. Howard, et al. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur J Immunol, 22 (1992) 711-717.] and enhanced antigen presentation capacities [C. Mohan, L. Morel, P. Yang, E.K. Wakeland, Accumulation of splenic B1a cells with potent antigen-presenting capability in NZM2410 lupus-prone mice. Arthritis and Rheumatism, 41 (1998) 1652-1662.], have implicated B-1a cells in autoimmunity. This review will discuss the current understandings of their role in autoimmune diseases with focus on lupus.

Entities:  

Mesh:

Year:  2005        PMID: 16890894     DOI: 10.1016/j.autrev.2005.10.007

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  110 in total

1.  Dermatan sulfate interacts with dead cells and regulates CD5(+) B-cell fate: implications for a key role in autoimmunity.

Authors:  Julia Y Wang; Jongmin Lee; Ming Yan; Jung-hyun Rho; Michael H A Roehrl
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Asbestos activates CH12.LX B-lymphocytes via macrophage signaling.

Authors:  Devon L Rasmussen; Jean C Pfau
Journal:  J Immunotoxicol       Date:  2011-12-01       Impact factor: 3.000

3.  Immunology: The expanding T(H)2 universe.

Authors:  Warren Strober
Journal:  Nature       Date:  2010-01-28       Impact factor: 49.962

Review 4.  The double life of a B-1 cell: self-reactivity selects for protective effector functions.

Authors:  Nicole Baumgarth
Journal:  Nat Rev Immunol       Date:  2010-12-10       Impact factor: 53.106

5.  Hiding in plain sight: time to unlock autoimmune clues in human CD5+ B cells by using nextgen technology.

Authors:  Rizwan Ahmed; Zahra Omidian; Thomas Donner; Abdel Rahiam A Hamad
Journal:  Discov Med       Date:  2018-09       Impact factor: 2.970

Review 6.  Contribution of B-1a cells to systemic lupus erythematosus in the NZM2410 mouse model.

Authors:  Zhiwei Xu; Laurence Morel
Journal:  Ann N Y Acad Sci       Date:  2015-02-26       Impact factor: 5.691

7.  CD22 expression mediates the regulatory functions of peritoneal B-1a cells during the remission phase of contact hypersensitivity reactions.

Authors:  Hiroko Nakashima; Yasuhito Hamaguchi; Rei Watanabe; Nobuko Ishiura; Yoshihiro Kuwano; Hitoshi Okochi; Yoshimasa Takahashi; Kunihiko Tamaki; Shinichi Sato; Thomas F Tedder; Manabu Fujimoto
Journal:  J Immunol       Date:  2010-03-24       Impact factor: 5.422

8.  Dermal immunopathology: from genetics to effector mechanisms.

Authors:  Akira Takashima; Fu-Tong Liu
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

9.  Primate B-1 cells generate antigen-specific B cell responses to T cell-independent type 2 antigens.

Authors:  Rama D Yammani; Karen M Haas
Journal:  J Immunol       Date:  2013-03-01       Impact factor: 5.422

Review 10.  Cell type-specific regulation of IL-10 expression in inflammation and disease.

Authors:  Christian M Hedrich; Jay H Bream
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.